The Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinases 2,9 in Osteosarcoma

李伟栩,叶招明,杨迪生,陶惠民

DOI: https://doi.org/10.3969/j.issn.1006-2785.2006.09.001

2006-01-01

Abstract:Objective To investigate the expression of MMP-2, MMP-9 and VEGF in osteosarcoma and the correlation between VEGF and MMPs. Methods The expression of VEGF, MMP-2 and MMP-9 was detected by immunohistochemical method (S-P) in 56 patients of osteosarcoma including 8 with metastasis. The samples were collected from the primary osteosarcoma and the metastasis foci. Results The positive rates of MMP-2 and MMP-9 were 53.6% and 53.6%, respectively. And the high expression of VEGF was found in 51.8% of the cases. The clinical prognosis was associated with the positive expressions of MMP-2, MMP-9, and the high expression of VEGF by Log-Rank test. Moreover, the positive rates of MMP-2, MMP-9 and VEGF were higher in the metastasis foci than those in the primary tumors. In the same case, the expressions of MMP-2, MMP-9 and VEGF in the primary tumor were consistent with those in the metastasis foci, respectively. Kendall analysis indicated that the expressions of MMP-2 and MMP-9 were associated with the expression of VEGF in osteosarcoma. COX hazard regression analysis showed that: (1) sex, tumor size, tumor subtype, and the method of surgery were not related to prognosis; (2) the expression of MMP-2, MMP-9 in osteosarcoma and the age of patient were independently associated with poor prognosis and high rate of metastasis; (3) VEGF expression had no association with prognosis which was contradict with the result by Log-Rank test. Conclusion The high expressions of MMP-2 and MMP-9 in the primary osteosarcoma indicated high risk of metastasis and poor prognosis and the expressions of MMP-2 and MMP-9 were associated with that of VEGF expression.